Acumen Pharmaceuticals, Inc. (ABOS) Tops Q1 EPS by 4c

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q1 EPS of ($0.33), $0.04 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval